spun out of mit, sqz biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient's immune system to combat disease. sqz: empower cells to change lives.
Company profile
Ticker
SQZB
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
SQZ Biotechnologies Security Corporation • SQZ Biotech HK Limited • SQZ Biotech (Shanghai) Co. Limited ...
IRS number
462431115
SQZB stock data
Latest filings (excl ownership)
DEFM14A
Proxy related to merger
23 Jan 24
PREM14A
Preliminary proxy related to merger
12 Jan 24
15-12G
Securities registration termination
4 Jan 24
8-K
Entry into a Material Definitive Agreement
22 Dec 23
EFFECT
Notice of effectiveness
4 Dec 23
POS AM
Prospectus update (post-effective amendment)
30 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Cost Associated with Exit or Disposal Activities
2 Oct 23
8-K
Termination of a Material Definitive Agreement
15 Sep 23
Latest ownership filings
SC 13G/A
AMERICAN INTERNATIONAL GROUP, INC.
13 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
4
PATRICK V.J.J. VINK
15 Jun 23
4
Sapna Srivastava
15 Jun 23
4
AMY W SCHULMAN
15 Jun 23
4
MARC SCHEGERIN
15 Jun 23
4
Klavs F. Jensen
15 Jun 23
4
Pushkal Garg
15 Jun 23
4
Marc Elia
15 Jun 23
4
Bernard Coulie
15 Jun 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 12.50 mm | 12.50 mm | 12.50 mm | 12.50 mm | 12.50 mm | 12.50 mm |
Cash burn (monthly) | 4.84 mm | 6.17 mm | 7.93 mm | 6.10 mm | 4.84 mm | 6.19 mm |
Cash used (since last report) | 28.77 mm | 36.69 mm | 47.18 mm | 36.27 mm | 28.80 mm | 36.84 mm |
Cash remaining | -16.28 mm | -24.19 mm | -34.68 mm | -23.77 mm | -16.31 mm | -24.34 mm |
Runway (months of cash) | -3.4 | -3.9 | -4.4 | -3.9 | -3.4 | -3.9 |
Institutional ownership, Q2 2023
62.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 33 |
Opened positions | 4 |
Closed positions | 6 |
Increased positions | 1 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 2.56 bn |
Total shares | 18.34 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Temasek | 2.76 mm | $744.71 mm |
Management Co. VII, L.L.C. Polaris | 2.73 mm | $24.36 mm |
AIG American International | 2.52 mm | $679.64 mm |
Artal | 1.61 mm | $434.00 k |
Artal International S.C.A. | 1.61 mm | $0.00 |
Invus Public Equities | 1.61 mm | $46.55 mm |
NanoDimension II Management | 1.45 mm | $0.00 |
Maverick Capital | 1.05 mm | $283.58 mm |
Vanguard | 941.09 k | $254.09 mm |
SF Stifel Financial | 851.52 k | $229.91 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | Paul Bolno | Stock Option Common Stock | Grant | Acquire A | No | No | 0.539 | 39,875 | 21.49 k | 39,875 |
14 Jun 23 | Bernard Coulie | Stock Option Common Stock | Grant | Acquire A | No | No | 0.539 | 39,875 | 21.49 k | 39,875 |
14 Jun 23 | Marc Elia | Stock Option Common Stock | Grant | Acquire A | No | No | 0.539 | 39,875 | 21.49 k | 39,875 |
14 Jun 23 | Klavs F. Jensen | Stock Option Common Stock | Grant | Acquire A | No | No | 0.539 | 39,875 | 21.49 k | 39,875 |
14 Jun 23 | Pushkal Garg | Stock Option Common Stock | Grant | Acquire A | No | No | 0.539 | 39,875 | 21.49 k | 39,875 |